{
    "references": [
        {
            "bibentry": "Denkers, EY, Schneider, AG, Cohen, SB, et al. Phagocyte responses to protozoan infection and how Toxoplasma gondii meets the challenge. PLoS Pathog 2012; 8: e1002794. PMID: 22876173",
            "process_entry": "True",
            "doi": "10.1371/journal.ppat.1002794",
            "pmid": "22876173",
            "pmcid": "PMC3410898",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Mui, EJ, Jacobus, D, Milhous, WK, et al. Triazine inhibits Toxoplasma gondii tachyzoites in vitro and in vivo. Antimicrob Agents Chemother 2005; 49: 3463–7. PMID: 16048961",
            "process_entry": "True",
            "doi": "10.1128/AAC.49.8.3463-3467.2005",
            "pmid": "16048961",
            "pmcid": "PMC1196210",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Innes, EA. Vaccination against Toxoplasma gondii: an increasing priority for collaborative research? Exp Rev Vaccine 2010; 9: 1117–1 9.",
            "process_entry": "True",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "D’Angelo, JG, Bordo, n. C ´, Posner, GH, et al. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle. J Antimicrob Chemoth 2009; 63: 146–50.",
            "process_entry": "True",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Zhang, HB, Shen, QK, Wang, H, et al. Synthesis and evaluation of novel arctigenin derivatives as potential anti-Toxoplasma gondii agents. Eur J Med Chem 2018; 158: 414–27. PMID: 30237124",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2018.08.087",
            "pmid": "30237124",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Dar, BA, Lone, AM, Shah, WA, et al. Synthesis and screening of ursolic acid-benzylidine derivatives as potential anti-cancer agents. Eur J Med Chem 2016; 111: 26–32. PMID: 26854375",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2016.01.026",
            "pmid": "26854375",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Liu, D, Meng, Y, Zhao, J, et al. Synthesis and anti-tumor activity of novel amide derivatives of ursolic acid. Chem Res Chinese Universities 2008; 24: 42–6.",
            "process_entry": "True",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Wu, PP, Zhang, K, Lu, YJ, et al. In vitro and in vivo evaluation of the antidiabetic activity of ursolic acid derivatives. Eur J Med Chem 2014; 80: 502–8. PMID: 24813878",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2014.04.073",
            "pmid": "24813878",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Ma, CM, Nakamura, N, Hattori, M, et al. Inhibitory effects on HIV-1 protease of constituents from the wood of Xanthoceras sorbifolia. J Nat Prod 2000; 63: 238–42. PMID: 10691716",
            "process_entry": "True",
            "doi": "10.1021/np9902441",
            "pmid": "10691716",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Keita, FT, Gasquet, M, Giorgio, CD, et al. Antimalarial activity of four plants used in traditional medicine in Mali. Phytother Res 2000; 14: 45–7. PMID: 10641048",
            "process_entry": "True",
            "doi": "10.1002/(sici)1099-1573(200002)14:1<45::aid-ptr544>3.0.co;2-c",
            "pmid": "10641048",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Chattopadhyay, D, Arunachalam, G, Mandal, AB, et al. Antimicrobial and anti-inflammatory activity of folklore: Mallotus peltatus leaf extract. J Ethnopharmacol 2002; 82: 229–37. PMID: 12242000",
            "process_entry": "True",
            "doi": "10.1016/s0378-8741(02)00165-4",
            "pmid": "12242000",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Wolska, KI, Grudniak, AM, Fiecek, B, et al. Antibacterial activity of oleanolic and ursolic acids and their derivatives. Cent Eur J Biol 2010; 5: 543–53.",
            "process_entry": "True",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Choi, WH, Lee, IA. Evaluation of anti-Toxoplasma gondii effect of ursolic acid as a novel toxoplasmosis inhibitor. Pharmaceuticals 2018; 11: 43–54.",
            "process_entry": "True",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Liu, MC, Yang, SJ, Jin, LH, et al. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety. Eur J Med Chem 2012; 58: 128–35. PMID: 23124210",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2012.08.048",
            "pmid": "23124210",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Rashid, S, Dar, BA, Majeed, R, et al. Synthesis and biological evaluation of ursolic acid-triazolyl derivatives as potential anti-cancer agents. Eur J Med Chem 2013; 66: 238–45. PMID: 23811086",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2013.05.029",
            "pmid": "23811086",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Stocks, MJ, Cheshire, DR, Reynolds, R. Efficient and regiospecific one-pot synthesis of substituted 1,2,4-triazoles. Org Lett 2004; 6: 2969–71. PMID: 15330660",
            "process_entry": "True",
            "doi": "10.1021/ol048863a",
            "pmid": "15330660",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Huang, X, Shen, QK, Zhang, HJ, et al. Design and synthesis of novel dehydroepiandrosterone analogues as potent antiproliferative agents. Molecules 2018; 23: 2243–56.",
            "process_entry": "True",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Sharling, L, Liu, X, Gollapalli, DR, et al. A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase. PLoS Neglect Trop D 2010; 4: e794.",
            "process_entry": "True",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Dzitko, K, Paneth, A, Plech, T, et al. Triazole-based compound as a candidate to develop novel medicines to treat toxoplasmosis. Antimicrob Agents Chemother 2014; 58: 7583–5. PMID: 25288090",
            "process_entry": "True",
            "doi": "10.1128/AAC.03832-14",
            "pmid": "25288090",
            "pmcid": "PMC4249526",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Luan, T, Cao, LH, Deng, H, et al. Design and synthesis of C-19 isosteviol derivatives as potent and highly selective antiproliferative agents. Molecules 2018; 24: 121–45.",
            "process_entry": "True",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Vidadala, RSR, Rivas, KL, Ojo, KK, et al. Development of an orally available and central nervous system (CNS) penetrant Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) Inhibitor with minimal human ether-a-go-go-related gene (hERG) activity for the treatment of toxoplasmosis. J Med Chem 2016; 59: 6531–46. PMID: 27309760",
            "process_entry": "True",
            "doi": "10.1021/acs.jmedchem.6b00760",
            "pmid": "27309760",
            "pmcid": "PMC5100899",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Schumacher, MA, Scott, DM, Mathews, II, et al. Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding. J Mol Biol 2000; 298: 875–93. PMID: 10801355",
            "process_entry": "True",
            "doi": "10.1006/jmbi.2000.3753",
            "pmid": "10801355",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Donaldson, TM, Cassera, MB, Ho, MC, et al. Inhibition and structure of Toxoplasma gondii purine nucleoside phosphorylase. Eukaryot Cell 2014; 13: 572–9. PMID: 24585883",
            "process_entry": "True",
            "doi": "10.1128/EC.00308-13",
            "pmid": "24585883",
            "pmcid": "PMC4060479",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Choi, HJ, Yu, ST, Lee, KI, et al. 6-Trifluoromethyl-2-thiouracil possesses anti-Toxoplasma gondii effect in vitro and in vivo with low hepatotoxicity. Exp Parasitol 2014; 143: 24–9. PMID: 24830752",
            "process_entry": "True",
            "doi": "10.1016/j.exppara.2014.05.002",
            "pmid": "24830752",
            "xmlid": "CIT0024"
        }
    ],
    "localid": "MED-30836795",
    "doi": "10.1080/14756366.2019.1584622",
    "pmid": "10.1080/14756366.2019.1584622",
    "pmcid": "30836795",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/30836795/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),332,67)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "CIT0002",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),585,213)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 2,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),585,213)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1002,177)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1002,177)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 5,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),240,244)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Pentacyclic triterpenes are a diverse and large class of natural products that are widely distributed in the plant kingdom. Over the decades, the synthesis of novel pentacyclic triterpenes has gained much attention in medicinal chemistry. Among these, ursolic acid (UA) and its derivatives have been reported to possess a wide range of biological activities, including anti-cancer6,7, anti-diabetic8, anti-HIV9, anti-malarial10, anti-microbial, and anti-inflammatory activities11,12. Until recently, Choi et al. reported that UA not only has strong anti-proliferative activity against T. gondii activity as well as increases survival of T. gondii-infected mice but also has the potential to be used as a promising anti-T. gondii candidate for developing effective anti-parasitic drugs13. To the best of our knowledge, studies related to anti-T. gondii activity of any UA derivatives have not yet been reported. Besides, the higher cytotoxicity in vitro and the low bioavailability in vivo of UA restrict its clinical application14,15. Therefore, the present study involved synthesis of different structurally modified compounds of UA with significantly improved anti-T. gondii activity and lower toxicity.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 6,
                "xref_id": "CIT0007",
                "rp_string": "7",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),240,244)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Pentacyclic triterpenes are a diverse and large class of natural products that are widely distributed in the plant kingdom. Over the decades, the synthesis of novel pentacyclic triterpenes has gained much attention in medicinal chemistry. Among these, ursolic acid (UA) and its derivatives have been reported to possess a wide range of biological activities, including anti-cancer6,7, anti-diabetic8, anti-HIV9, anti-malarial10, anti-microbial, and anti-inflammatory activities11,12. Until recently, Choi et al. reported that UA not only has strong anti-proliferative activity against T. gondii activity as well as increases survival of T. gondii-infected mice but also has the potential to be used as a promising anti-T. gondii candidate for developing effective anti-parasitic drugs13. To the best of our knowledge, studies related to anti-T. gondii activity of any UA derivatives have not yet been reported. Besides, the higher cytotoxicity in vitro and the low bioavailability in vivo of UA restrict its clinical application14,15. Therefore, the present study involved synthesis of different structurally modified compounds of UA with significantly improved anti-T. gondii activity and lower toxicity.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 7,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),240,244)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Pentacyclic triterpenes are a diverse and large class of natural products that are widely distributed in the plant kingdom. Over the decades, the synthesis of novel pentacyclic triterpenes has gained much attention in medicinal chemistry. Among these, ursolic acid (UA) and its derivatives have been reported to possess a wide range of biological activities, including anti-cancer6,7, anti-diabetic8, anti-HIV9, anti-malarial10, anti-microbial, and anti-inflammatory activities11,12. Until recently, Choi et al. reported that UA not only has strong anti-proliferative activity against T. gondii activity as well as increases survival of T. gondii-infected mice but also has the potential to be used as a promising anti-T. gondii candidate for developing effective anti-parasitic drugs13. To the best of our knowledge, studies related to anti-T. gondii activity of any UA derivatives have not yet been reported. Besides, the higher cytotoxicity in vitro and the low bioavailability in vivo of UA restrict its clinical application14,15. Therefore, the present study involved synthesis of different structurally modified compounds of UA with significantly improved anti-T. gondii activity and lower toxicity.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 8,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),240,244)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Pentacyclic triterpenes are a diverse and large class of natural products that are widely distributed in the plant kingdom. Over the decades, the synthesis of novel pentacyclic triterpenes has gained much attention in medicinal chemistry. Among these, ursolic acid (UA) and its derivatives have been reported to possess a wide range of biological activities, including anti-cancer6,7, anti-diabetic8, anti-HIV9, anti-malarial10, anti-microbial, and anti-inflammatory activities11,12. Until recently, Choi et al. reported that UA not only has strong anti-proliferative activity against T. gondii activity as well as increases survival of T. gondii-infected mice but also has the potential to be used as a promising anti-T. gondii candidate for developing effective anti-parasitic drugs13. To the best of our knowledge, studies related to anti-T. gondii activity of any UA derivatives have not yet been reported. Besides, the higher cytotoxicity in vitro and the low bioavailability in vivo of UA restrict its clinical application14,15. Therefore, the present study involved synthesis of different structurally modified compounds of UA with significantly improved anti-T. gondii activity and lower toxicity.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 9,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),240,244)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Pentacyclic triterpenes are a diverse and large class of natural products that are widely distributed in the plant kingdom. Over the decades, the synthesis of novel pentacyclic triterpenes has gained much attention in medicinal chemistry. Among these, ursolic acid (UA) and its derivatives have been reported to possess a wide range of biological activities, including anti-cancer6,7, anti-diabetic8, anti-HIV9, anti-malarial10, anti-microbial, and anti-inflammatory activities11,12. Until recently, Choi et al. reported that UA not only has strong anti-proliferative activity against T. gondii activity as well as increases survival of T. gondii-infected mice but also has the potential to be used as a promising anti-T. gondii candidate for developing effective anti-parasitic drugs13. To the best of our knowledge, studies related to anti-T. gondii activity of any UA derivatives have not yet been reported. Besides, the higher cytotoxicity in vitro and the low bioavailability in vivo of UA restrict its clinical application14,15. Therefore, the present study involved synthesis of different structurally modified compounds of UA with significantly improved anti-T. gondii activity and lower toxicity.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 10,
                "xref_id": "CIT0011",
                "rp_string": "11",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),240,244)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Pentacyclic triterpenes are a diverse and large class of natural products that are widely distributed in the plant kingdom. Over the decades, the synthesis of novel pentacyclic triterpenes has gained much attention in medicinal chemistry. Among these, ursolic acid (UA) and its derivatives have been reported to possess a wide range of biological activities, including anti-cancer6,7, anti-diabetic8, anti-HIV9, anti-malarial10, anti-microbial, and anti-inflammatory activities11,12. Until recently, Choi et al. reported that UA not only has strong anti-proliferative activity against T. gondii activity as well as increases survival of T. gondii-infected mice but also has the potential to be used as a promising anti-T. gondii candidate for developing effective anti-parasitic drugs13. To the best of our knowledge, studies related to anti-T. gondii activity of any UA derivatives have not yet been reported. Besides, the higher cytotoxicity in vitro and the low bioavailability in vivo of UA restrict its clinical application14,15. Therefore, the present study involved synthesis of different structurally modified compounds of UA with significantly improved anti-T. gondii activity and lower toxicity.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "CIT0012",
                "rp_string": "12",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),240,244)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 12,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),485,303)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 13,
                "xref_id": "CIT0014",
                "rp_string": "14",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),912,123)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 14,
                "xref_id": "CIT0015",
                "rp_string": "15",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),912,123)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 18,
                "xref_id": "CIT0016",
                "rp_string": "16–18",
                "pl_string": "16–18",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,174)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 16,
                "xref_id": "",
                "pl_string": "16–18",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,174)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 17,
                "xref_id": "",
                "pl_string": "16–18",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,174)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 18,
                "xref_id": "CIT0016",
                "rp_string": "16–18",
                "pl_string": "16–18",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,174)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 19,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),410,129)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 20,
                "xref_id": "CIT0019",
                "rp_string": "19",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),659,192)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 21,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p),1,86)",
                "containers_title": [
                    "Materials and methods",
                    "General procedure for synthesis of intermediates (UA-1, Ia-Ij, IIa-IIe, IIIa-IIIe)"
                ]
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p),88,188)",
                "containers_title": [
                    "Materials and methods",
                    "General procedure for synthesis of intermediates (UA-1, Ia-Ij, IIa-IIe, IIIa-IIIe)"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0020",
                "rp_string": "20",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p),88,188)",
                "containers_title": [
                    "Materials and methods",
                    "General procedure for synthesis of intermediates (UA-1, Ia-Ij, IIa-IIe, IIIa-IIIe)"
                ]
            }
        ],
        [
            {
                "n_rp": 24,
                "xref_id": "CIT0021",
                "rp_string": "21",
                "rp_xpath": "/article/body/sec[2]/sec[8]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[8]/p),235,207)",
                "containers_title": [
                    "Materials and methods",
                    "Molecular docking"
                ],
                "pl_string": "Molecular docking was performed using the Discovery Studio (DS) 2017 software. The protein and ligand samples were prepared, water molecules were deleted, and a DS Server added hydrogen. The docking result was treated with DS Client. In this study, three crystal structures of the proteins were selected for docking, PDB ID: 6BFA (calcium-dependent protein kinase 1)21, 1LII (adenosine kinase)22 and 3MB8 (purine nucleoside phosphorylase)23. The different xyz coordinates and radii of these proteins were defined as the binding site spheres. The output poses of the ligands generated were analysed using the LibDockScore function to find out the best complimentary match between the ligand and the receptor. The protocol, CDOCKER was used to perform the docking.",
                "pl_xpath": "/article/body/sec[2]/sec[8]/p"
            },
            {
                "n_rp": 25,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[2]/sec[8]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[8]/p),235,207)",
                "containers_title": [
                    "Materials and methods",
                    "Molecular docking"
                ],
                "pl_string": "Molecular docking was performed using the Discovery Studio (DS) 2017 software. The protein and ligand samples were prepared, water molecules were deleted, and a DS Server added hydrogen. The docking result was treated with DS Client. In this study, three crystal structures of the proteins were selected for docking, PDB ID: 6BFA (calcium-dependent protein kinase 1)21, 1LII (adenosine kinase)22 and 3MB8 (purine nucleoside phosphorylase)23. The different xyz coordinates and radii of these proteins were defined as the binding site spheres. The output poses of the ligands generated were analysed using the LibDockScore function to find out the best complimentary match between the ligand and the receptor. The protocol, CDOCKER was used to perform the docking.",
                "pl_xpath": "/article/body/sec[2]/sec[8]/p"
            },
            {
                "n_rp": 26,
                "xref_id": "CIT0023",
                "rp_string": "23",
                "rp_xpath": "/article/body/sec[2]/sec[8]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[8]/p),235,207)",
                "containers_title": [
                    "Materials and methods",
                    "Molecular docking"
                ],
                "pl_string": "Molecular docking was performed using the Discovery Studio (DS) 2017 software. The protein and ligand samples were prepared, water molecules were deleted, and a DS Server added hydrogen. The docking result was treated with DS Client. In this study, three crystal structures of the proteins were selected for docking, PDB ID: 6BFA (calcium-dependent protein kinase 1)21, 1LII (adenosine kinase)22 and 3MB8 (purine nucleoside phosphorylase)23. The different xyz coordinates and radii of these proteins were defined as the binding site spheres. The output poses of the ligands generated were analysed using the LibDockScore function to find out the best complimentary match between the ligand and the receptor. The protocol, CDOCKER was used to perform the docking.",
                "pl_xpath": "/article/body/sec[2]/sec[8]/p"
            }
        ],
        [
            {
                "n_rp": 27,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[3]/sec[6]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[6]/p),548,130)",
                "containers_title": [
                    "Results and discussion",
                    "MDA and GSH"
                ]
            }
        ],
        [
            {
                "n_rp": 31,
                "xref_id": "CIT0021",
                "rp_string": "21–23",
                "pl_string": "21–23",
                "rp_xpath": "/article/body/sec[3]/sec[7]/p[1]/xref[1]",
                "pl_xpath": "/article/body/sec[3]/sec[7]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[7]/p[1]),1,196)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular docking analysis"
                ]
            },
            {
                "n_rp": 29,
                "xref_id": "",
                "pl_string": "21–23",
                "pl_xpath": "/article/body/sec[3]/sec[7]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[7]/p[1]),1,196)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular docking analysis"
                ]
            },
            {
                "n_rp": 30,
                "xref_id": "",
                "pl_string": "21–23",
                "pl_xpath": "/article/body/sec[3]/sec[7]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[7]/p[1]),1,196)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular docking analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 31,
                "xref_id": "CIT0021",
                "rp_string": "21–23",
                "pl_string": "21–23",
                "rp_xpath": "/article/body/sec[3]/sec[7]/p[1]/xref[1]",
                "pl_xpath": "/article/body/sec[3]/sec[7]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[7]/p[1]),1,196)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular docking analysis"
                ]
            }
        ]
    ]
}